Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DSP-6952 (minesapride) single- and multiple-ascending dose and food-effect study in healthy volunteers and subjects with infrequent bowel movements
jRCT2080223728Phase 1Completed
- Sponsor
- Sumitomo Pharma
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of minesapride in constipation (7 arms), sponsored by Sumitomo Pharma. Primary endpoints: Safety and tolerability of DSP-6952, Pharmacokinetics of DSP-6952 and 1 more. Started Nov 2017; status: completed.
02
Drugs
minesapride
03
Conditions
constipation
Beyond the preview
Go deeper on jRCT2080223728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223728.